Efficacy of of Acupuncture Laser Therapy on Hemodialysis Patients

ConditionHemodialysis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 60
SponsorSinai University

About this trial

This expected prospective randomized control trial study will involve 60 haemodialysis patients with neck pain. The patients in the experimental group (E) will subject, medical treatment besides acupuncture laser therapy. Medical treatment will be used in the control group (C). Pain and quality of life assessment will be used in the assessment of outcome.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Acupuncture Laser Therapy

    Device

    Participants will receive low-level laser therapy sessions during dialysis , applied three times per week for 4 weeks to selected treatment areas.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Efficacy of of Acupuncture Laser Therapy on HemodialysisExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

change in pain scales

visual analogue scale

Time frame
baseline and after 2 weeks of treatment
2

change in Quality of life scale

Chronic neck pain is a common issue among individuals undergoing hemodialysis, often resulting from factors such as poor posture during treatments, muscle tension, and underlying health conditions. Traditional pain management strategies may not always provide adequate relief and can have undesirable side effects, especially in patients with complex medical histories.

Time frame
baseline and after 2 weeks of treatment
3

change of perceived stress scale

Chronic neck pain is a common issue among individuals undergoing hemodialysis, often resulting from factors such as poor posture during treatments, muscle tension, and underlying health conditions. Traditional pain management strategies may not always provide adequate relief and can have undesirable side effects, especially in patients with complex medical histories.

Time frame
Baseline and after 4 weeks of treatment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: